Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The RASopathies: from pathogenetics to therapeutics
Katie E. Hebron, Edjay R. Hernandez, Marielle E. Yohe
Disease Models & Mechanisms (2022) Vol. 15, Iss. 2
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

BRAF — a tumour-agnostic drug target with lineage-specific dependencies
Aphrothiti J. Hanrahan, Ziyu Chen, Neal Rosen, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 3, pp. 224-247
Closed Access | Times Cited: 38
Clinical overview on RASopathies
Martin Zenker
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 4, pp. 414-424
Open Access | Times Cited: 49
Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS
Guowei Yin, Jing Huang, Johnny Petela, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 27
Targeted Therapies in Pediatric and Adult Patients With Hypertrophic Heart Disease: From Molecular Pathophysiology to Personalized Medicine
Emanuele Monda, Athanasios Bakalakos, Marta Rubino, et al.
Circulation Heart Failure (2023) Vol. 16, Iss. 8
Open Access | Times Cited: 24
Neurodevelopmental disorders and cancer networks share pathways, but differ in mechanisms, signaling strength, and outcome
Bengi Ruken Yavuz, M. Kaan Arici, Habibe Cansu Demirel, et al.
npj Genomic Medicine (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 22
Signaling from RAS to RAF: The Molecules and Their Mechanisms
Hyesung Jeon, Emre Tkacik, Michael J. Eck
Annual Review of Biochemistry (2024) Vol. 93, Iss. 1, pp. 289-316
Closed Access | Times Cited: 11
Health outcomes and drug utilisation in children with Noonan syndrome: a European cohort study
Michele Santoro, Ingeborg Barišić, Alessio Coi, et al.
Orphanet Journal of Rare Diseases (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
RASopathy mutations provide functional insight into the BRAF cysteine-rich domain and reveal the importance of autoinhibition in BRAF regulation
Russell Spencer-Smith, Elizabeth M. Terrell, Christine Insinna, et al.
Molecular Cell (2022) Vol. 82, Iss. 22, pp. 4262-4276.e5
Open Access | Times Cited: 24
New prospectives on treatment opportunities in RASopathies
Bruce D. Gelb, Marielle E. Yohe, Cordula M. Wolf, et al.
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 4, pp. 541-560
Open Access | Times Cited: 23
The therapeutic potential of neurofibromin signaling pathways and binding partners
Juan Báez-Flores, Mario Rodríguez-Martín, Jesús Lacal
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 15
Cell phenotypes can be predicted from propensities of protein conformations
Ruth Nussinov, Yonglan Liu, Wengang Zhang, et al.
Current Opinion in Structural Biology (2023) Vol. 83, pp. 102722-102722
Open Access | Times Cited: 13
Novel use of trametinib for treatment of atrial arrhythmia in absence of cardiomyopathy in a patient with Costello syndrome
A Kato, Natalie Shwaish, Eui-Seock Hwang, et al.
Cardiology in the Young (2025), pp. 1-3
Closed Access
YAP/TAZ-associated cell signaling – at the crossroads of cancer and neurodevelopmental disorders
Aderonke O. Ajongbolo, Sigrid A. Langhans
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Decoding Hearts: Genetic Insights and Clinical Strategies in Congenital Heart Disease
Christopher M. Stark, Brian N. Hughes, John P. Schacht, et al.
NeoReviews (2025) Vol. 26, Iss. 2, pp. e73-e88
Closed Access
Trametinib as a targeted treatment in cardiac and lymphatic presentations of Noonan syndrome
Isabel De Brouchoven, Juan Lorand, Léon Bofferding, et al.
Frontiers in Pediatrics (2025) Vol. 13
Open Access
Different Ras isoforms regulate synaptic plasticity in opposite directions
Esperanza López-Merino, Alba Fernández‐Rodrigo, Jessie G. Jiang, et al.
The EMBO Journal (2025)
Open Access
Noonan syndrome combined with juvenile xanthogranuloma in a newborn
D. M. Mushcherova, U. S. Severgina, A. P. Khokhlova, et al.
Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) (2025) Vol. 70, Iss. 1, pp. 64-69
Open Access
Targeting RAS and associated proteins
Matthias Müller, Roger S. Goody, Daniel Rauh
Elsevier eBooks (2025)
Closed Access
The “DDVF” motif used by viral and bacterial proteins to hijack RSK kinases mimics a short linear motif (SLiM) found in proteins related to the RAS-ERK MAP kinase pathway
Martin Veinstein, Vincent Stroobant, Fanny Wavreil, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 3, pp. e1013016-e1013016
Open Access
Molecular genetics of congenital heart disease
Xiaoqing Zhang, Ming Qi, Qihua Fu
Science China Life Sciences (2025)
Closed Access
Cardiovascular aspects of Noonan syndrome and related disorders
Martin Zenker, Cordula M. Wolf
Medizinische Genetik (2025) Vol. 37, Iss. 2, pp. 113-124
Closed Access
Defining the variant-phenotype correlation in patients affected by Noonan syndrome with the RAF1:c.770C>T p.(Ser257Leu) variant
Andrea Gazzin, Federico Fornari, Marcello Niceta, et al.
European Journal of Human Genetics (2024) Vol. 32, Iss. 8, pp. 964-971
Closed Access | Times Cited: 4
Functional and structural insights into RAS effector proteins
Alessandro M. Mozzarelli, Dhirendra K. Simanshu, Pau Castel
Molecular Cell (2024) Vol. 84, Iss. 15, pp. 2807-2821
Closed Access | Times Cited: 4
Undiagnosed RASopathies in infertile men
Anna-Grete Juchnewitsch, Kristjan Pomm, Avirup Dutta, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Reverse repurposing: Potential utility of cancer drugs in nonmalignant illnesses
Mina Nikanjam, Kaitlyn Wells, Shumei Kato, et al.
Med (2024) Vol. 5, Iss. 7, pp. 689-717
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top